Drug Profile


Alternative Names: KRX 0701

Latest Information Update: 27 Jul 2009

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Meda
  • Class Carboxylic acids; Eye disorder therapies; Propylene glycols; Small molecules
  • Mechanism of Action Oxygen radical formation antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Diabetic retinopathy; Type 2 diabetes mellitus

Most Recent Events

  • 06 May 2009 Discontinued - Phase-II for Type-2 diabetes mellitus in Germany (PO)
  • 05 Sep 2007 This compound is still in active development
  • 16 Jun 2004 Preclinical trials in Diabetic retinopathy in Germany (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top